New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...

CD25 expression has long been recognized as an adverse prognostic marker in acute leukemias including acute myeloid leukemia ...

Acute myeloid leukemia (AML) is a particularly aggressive form of blood cancer that usually progresses rapidly if swift and intensive treatment is not applied. Although the disease can often be ...

CD25 rewires oncogene signaling in AML and ALL, revealing druggable complexes and a bold strategy: push pathways into toxic ...

Soheil Meshinchi, MD, PhD, a world leader in developing novel approaches to treating acute myeloid leukemia (AML), has been ...

ROANOKE, Va. (WDBJ) - A Roanoke-based nonprofit founded in memory of a young woman diagnosed with a rare form of leukemia is marking seven years of service to young adults facing cancer treatment.

The diagnosis of acute leukaemia in children, most notably acute lymphoblastic leukaemia (ALL), remains a critical challenge in paediatric medicine. A significant proportion of patients present with ...

Blackstone Life Sciences ("BXLS") today announced a research and development funding agreement to advance the clinical ...

Kerynn Morss is still looking for a donor match for her son Broeden Sabin, who was diagnosed with acute myeloid leukemia in ...